Columns

EN

2026.03.07

High-Concentration Minoxidil Import: Safe Use of Topical Solutions Over 15% | TASAKI PHAMA

For those considering importing high-concentration...

Read More

EN

2026.03.07

NAD+ IV Drip Import: Latest Information on US Formulations Safety and Vascular Pain Risk | TASAKI PHAMA

[Latest] Information regarding the import of NAD+ ...

Read More

EN

2026.03.07

LHALALA Peel Introduction: No-Downtime 4th Generation Peeling – Guide for Aesthetic Dermatology Clinics | TASAKI PHAMA

For aesthetic dermatologists considering introduci...

Read More

EN

2026.03.07

GT20029 Import: Potential of Next-Generation Androgen Receptor Degraders from China | TASAKI PHAMA

A professional explanation of GT20029, the latest ...

Read More

EN

2026.03.07

Hyaluronic Acid Import: Juvéderm, Restylane, and Neuramis Cost and Quality Comparison | TASAKI PHAMA

Information on the import of hyaluronic acid fille...

Read More

EN

2026.03.07

Jalupro Import: A Comprehensive Guide to Italian ECM Preparation for Skin Regeneration | TASAKI PHAMA

Jalupro is an Italian-made ECM preparation effecti...

Read More

EN

2026.03.07

DR.CYJ Hair Filler Import: Mechanism of Action and Benefits for Women | TASAKI PHAMA

DR.CYJ Hair Filler is gaining attention as a FAGA ...

Read More

EN

2026.03.07

How to Choose a Pharmaceutical Trading Company: Checkpoints for Selecting a GDP-Compliant Specialist | TASAKI PHAMA

We explain how to choose a pharmaceutical trading ...

Read More

EN

2026.03.07

NCTF135HA (Filorga) ‘Chanel Injection’ Import: Beauty Benefits and Import Guidelines for Clinics | TASAKI PHAMA

Chanel Injection (NCTF135HA) is a beauty treatment...

Read More